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Available online 29 February 2008The primary lung bud originates from the foregut and develops into the bronchial tree by repetitive branching
and outgrowing of the airway. The Sry related HMG box protein Sox2 is expressed in a cyclic manner during
initiation and branchingmorphogenesis of the lung. It is highly expressed in non-branching regions and absent
from branching regions, suggesting that downregulation of Sox2 is mandatory for airway epithelium to
respond to branch inducing signals. Therefore, we developed transgenic mice that express a doxycycline
inducible Sox2 in the airway epithelium. Continuous expression of Sox2 hampers the branching process
resulting in a severe reduction of the number of airways. In addition, the bronchioli transiently go over into
enlarged, alveolar-like airspaces, a pathology described as bronchiolization of alveoli. Furthermore, a
substantial increasewas observed of cGRP positive neuroendocrine cells and ΔNp63 isoform expressing (pre-)
basal cells, which are both committed precursor-like cells. Thus, Sox2 prevents airways from branching and
prematurely drives cells into committed progenitors, apparently rendering these committed progenitors
unresponsive to branch inducing signals. However, Sox2 overexpressiondoes not lead to a complete abrogation
of the epithelial differentiation program.







The mechanisms involved in patterning, development and differ-
entiation of the foregut and lung are only recently beginning to be
understood at themolecular level. It has becomeclear that the intimate
interactions between the mesenchyme and endodermal epithelium
are mandatory for formation and completion of lung development.
Gene inactivation and transgenic expression studies in mice have
shown the importance of individual factors at different phases of lung
development (Cardoso and Lu, 2006; Maeda et al., 2007). The primary
bronchial tree develops by a process of repetitive branching of the
airways, called branching morphogenesis. The secreted growth factor
Fgf10 induces formation of the ﬁrst morphological sign of the lung, the
lung bud, by activating the Fgfr2b receptor (Bellusci et al., 1997b; Park
et al., 1998; Sutherland et al., 1996; Weaver et al., 2000). Mice lacking
either Fgf10 or the Fgfr2b do not form lungs, indicating the
requirement of this growth factor signaling pathway for the lung
initiation (De Moerlooze et al., 2000; Min et al., 1998; Sekine et al.,
1999). Moreover, local Fgf10 expression in the mesenchyme induces
the activation of the Fgfr2b receptor on cells of the surrounding airway
epithelium, triggering the activation of downstream genes like Spry2,
Shh and Bmp4 (Litingtung et al., 1998; Mailleux et al., 2001; WeaverSurgery/Cell Biology, PO Box
4089468.
l rights reserved.et al.,1999). These signalingmolecules subsequently invoke a feedback
mechanism that controls correct budding, growth and differentiation
of the epithelium and mesenchyme. Continuous growth, budding and
elongation of the airway epithelium are subject to interactions with
the surrounding mesenchyme and involves various signaling cascades
(reviewed in Cardoso and Lu, 2006; Maeda et al., 2007).
A crucial event in lung development after formation of the lung
bud is the repetitive branching of the airways to develop into the
primary bronchial tree. Based on the expression pattern, a putative
role in the formation of the lung, trachea and esophagus for Sox2 was
suggested at this stage of lung development (Ishii et al., 1998). Sox2 is
part of a highly conserved family of transcription factors with the sex-
determining gene Sry as the founding member. Although they share
similar DNA binding properties, individual Sox proteins appear to
regulate speciﬁc sets of target genes in vivo by restricted patterns of
expression and in combination with speciﬁc interacting partners. Sox
proteins are recognized as key players in the regulation of embryonic
development and determination of cell fate and maintenance
(Kamachi et al., 2000; Lefebvre et al., 2007; Schepers et al., 2002;
Wilson and Koopman, 2002). Sox2 is cell-autonomously required in
both embryonic and extra-embryonic cell types, and the lack of Sox2
results in peri-implantation lethality (Avilion et al., 2003). Sox2,
together with Oct3/4 and Nanog, plays a pivotal role in the main-
tenance of ES cell pluripotency by regulating lineage commitment
factors (Boyer et al., 2005; Ivanova et al., 2006; Rao and Orkin, 2006;
Wang et al., 2006). Later in development, Sox2 is involved in spe-
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(Bylund et al., 2003; Graham et al., 2003; Pevny and Placzek, 2005).
Sox2 also regulates neural progenitor cell differentiation in the retina
and the formation of sensory hair cells and supportive cells in the
cochlea (Kiernan et al., 2005; Taranova et al., 2006).
Sox2 is expressed in the endoderm of the foregut from the pha-
ryngeal arches down to the future stomach, and later in organs
derived form the foregut. Using hypomorphic mouse mutants with
reduced Sox2 expression, Que et al. (2007) demonstrated that Sox2 is
involved in the morphogenesis of the trachea and esophagus, as well
as the differentiation of the esophageal epithelium. The timing and
localization of Sox2 expression in the foregut appears tightly
regulated, as it is switched off at the site where the lung buds.
Subsequently, after the outgrowth of the bud, Sox2 expression
reappears, only to be shut down again the moment that this bud
starts to branch. Again, Sox2 expression is reinstalled after these
branches are growing out and the leading tip of the growing branch
is moving away from the branching site (Ishii et al., 1998). Therefore,
we hypothesized that downregulation of Sox2 at these branching
sites is crucial for correct development of the lung.
We investigated the role of Sox2 during early lung development
and differentiation of the airway epithelium using conditional over-
expression of Sox2 in the epithelial cells of the lung. We show that
Sox2 activity affects two processes during lung development. First, it is
implicated in branching morphogenesis of the bronchial tree, since
overexpression leads to severe disruption of the formation of the
airway branches. Sox2 downregulation at branching sites is required
for cells to respond to branch-inducing signals and to maintain these
cells undifferentiated. Second, we show that Sox2 is required for dif-
ferentiation of the epithelium of the airways, since overexpression
leads to a premature commitment of cells towards differentiation. We
show that aberrant Sox2 expression leads to an increase in the
number of neuroendocrine cells, (pre-) basal cells and cells with a
gastric/intestinal expression pattern.
Materials and methods
Generation of transgenic animals
A 3.6 kb HindIII–SalI murine genomic fragment containing the Sox2 coding region
was isolated and a myc epitope encoding sequence was cloned right after the endo-
genous ATG. This fragment was subsequently cloned into the pTRE-Tight vector (pTT::
myc-sox2; Clontech). An AatII–DraI fragment was used for pronuclear injection to
produce transgenic lines. Tail tip DNA of transgenic lines was initially genotyped by
Southern blot analysis, after which positive lines were routinely checked by PCR, using a
transgene-speciﬁc primer combination (sense 5′-GCAGAAGCTGATCTCGGAGG-3′; anti-
sense 5′-CTGGTCATGGAGTTGTACTGCAGG-3′). Mice were kept under standard condi-
tions and all experiments were performed according to the guidelines of the local ethics
committee. Lung-speciﬁc overexpression of the myc-Sox2 transgene was obtained by
crossing the myc-Sox2 lines with SPC-rtTA transgenic mice (gift of Jeffrey Whitsett,
Cincinnati). Administration of doxycycline to dams from gestational age 6.5 onward in
the drinking water (2 mg/ml doxycycline, 5% sucrose) resulted in lung epithelium-
speciﬁc expression. Each experiment was executed on at least three litters containing
double transgenic, single transgenic and wild type pups. Three independent transgenic
lines have been tested with identical results.
Histology
Lungs were dissected and ﬁxed in 4% PFA overnight at 4 °C before processing for
parafﬁn embedding according to routine protocols (Canis Parera et al., 2005; van Tuyl
et al., 2005). Antigen retrieval was performedwithmicrowave treatment in 10mMcitric
acid buffer pH 6.0. Sections were blocked with 5% BSA in PBS for 10 min and incubated
with primary antibody diluted in 5% BSA in PBS overnight at 4 °C. The following
antibodies were used: Sox2 (Chemicon), β-tubulin IV (Biogenex), proSP-C (Chemicon),
cGRP (Sigma), CC10 (rabbit polyclonal, kindly provided by B. Stripp), T1α (University of
Iowa Hybridoma bank, mAb 8.1.1; 1:100), myc (Roche), α-SM actin (NeoMarkers) Ttf1
(Neomarkers), Foxa2 (Seven Hills Bioreagents), p63 (Santa Cruz), phospho-SMAD1/5/8
(Cell Signaling Technology), phospho-ERK1/2 (Cell Signaling Technology), cleaved
caspase-3 (Cell Signaling Technology), phospho-Histone H3 (Upstate Biotechnology),
Krt14 (Monosan) and Fli-1 (Santa Cruz). The Sox2 immunohistochemistry was carried
out using the Envision+ System (DAKO), StreptABC complex/HRP (DAKO) and HRP-DAB
colorimetric detection. Secondary antibodies against the correct IgG species were
conjugatedwith peroxidase (Dako), Alexa594 (molecular Probes) and FITC (Nordic Labs).Whole-mount β-galactosidase staining to visualize the pulmonary vasculature was
performed as previously described (Canis Parera et al., 2005). Whole-mount in situ
hybridization was essentially performed as described (Ishii et al., 1998). The following
mouse cDNAs were used as templates for the synthesis of digoxigenin-labeled
riboprobes: a 1077 bp Bmp4 cDNA and a 634 bp Shh cDNA, according to the protocol
supplied by Roche Diagnostics.
Microarray analysis
Lungs of 6 littermates (pTT::myc-SOX2+/− * SPC-rtTA+/−) were dissected at E18.5 and
the middle and caudal lobes were used for total RNA isolation with Trizol reagent
according to the manufacturer’s instructions (Invitrogen life technologies, Carlsbad, CA,
USA). RNA was puriﬁed using the RNeasy MinElute Cleanup kit (Qiagen, Valencia, CA,
USA) and cDNA was synthesized from 3 μg RNA using the GeneChip Expression 3′-
Ampliﬁcation Reagents One-Cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA,
USA). Biotin-labeled cRNA synthesis, puriﬁcation and fragmentation were performed
according to standard conditions. Fragmented biotinylated cRNA was subsequently
hybridized onto Affymetrix Mouse Genome 430 2.0 microarray chips. After normal-
ization, the data were analyzed with OmniViz software, version 3.6.0 (Omniviz, Inc.,
Maynard, MA, USA).
RT-PCR
Total RNA was isolated with Trizol reagent and 2 μg was used to prepare cDNA
(Invitrogen). Primer sets for the PCR were myc-Sox2: 5′-GCAGAAGCTGATCTCGGAGG-3′
and 5′-CTGGTCATGGAGTTGTACTGCAGG-3′; Sox21: 5′-GCAGTTGGTGTTTGCTTTGC-3′
and 5′-ACTGACAACTTCCACCTCACA-3′; HPRT: 5′-GCTGGTGAAAAGGACCTCTC-3′ and
5′-CACAGGACTAGAACACCTGC-3′; all other primer sets were previously described (Li
et al., 2005; Okubo and Hogan, 2004; Okubo et al., 2005; Perl et al., 2005; Que et al.,
2007; Serls et al., 2005; Wan et al., 2005).
Results
Endogenous expression of sox2 in the lung
We ﬁrst studied Sox2 expression during the different phases of
murine embryonic lung development. Initially, it is expressed in the
epithelial cells of the rostral part of the primitive gut up to the future
stomach (Ishii et al., 1998). It is locally downregulated at the ventral
side of the foregut at the side where the lung bud appears (E9.5; Fig.
1A). As soon as the lung bud is established, Sox2 protein is expressed
again in the epithelial cells (Fig. 1B). The expression of Ttf1 is
reciprocal from Sox2 expression, as has also been shown previously
(Fig. 1A, insert; Que et al., 2007). When the right and left main bronchi
are forming, Sox2 expression vanishes again, and reappears after these
primary branches have developed (Figs.1B, C). This speciﬁc expression
pattern of Sox2, being upregulated and subsequently downregulated
in the epithelial cells at sites where the bronchial tree branches, is
repeated several times during the embryonal (Figs. 1A, B), pseudo-
glandular (Figs. 1C–E), canalicular (Fig. 1F), saccular (Fig. 1G) and
alveolar phases of lung development (Fig. 1H). Sox2 remains highly
expressed in the proximal airways and in the postnatal 3 weeks old
lung it is primarily expressed in the epithelium of the conducting
airways (Fig. 1H). Sox2 expression is excluded from the (primitive)
alveoli, as can be seen from the strict border between the bronchioli
and alveoli, the bronchioalveolar duct junction (inserts, Figs. 1F–H).
Conditional overexpression of Sox2 in embryonic lungs
Downregulation of Sox2 expression appears a prerequisite for air-
ways to branch and hence continued expression of Sox2 should inhibit
normal branching. We therefore generated an inducible myc-tagged
Sox2 transgene under the control of a tet-on promoter. Expression
in embryonic lung epithelial cells was established by crossing the
Sox2 line with the SPC-rtTA line (Perl et al., 2002). The SPC promoter
drives expression of the rtTA gene in epithelial cells of the embryonal
lung, and the rtTA protein can activate the tet-on promoter under the
inﬂuence of doxycycline. Lungs isolated from single transgenic or
non-induced double transgenic fetuses appeared healthy and showed
no macroscopic or microscopic abnormalities. However, double
transgenic pups that were given doxycycline succumbed within half
Fig. 1. Sox2 expression during wild-type lung development. (A) At E9.5, Sox2 was detected in epithelial cells of the foregut, reciprocal to Ttf1 expression in the lung bud (insert). Sox2
is exclusively expressed in the epithelial cells of the non-branching developing airways at E10.5 (B), E11.5 (C), E13.5 (D) and E14.5 (E). Sox2 remained expressed in epithelial cells of
the conducting airways at E 16.5 (F), E18.5 (G) and PN21 (H) with a sharp boundary at the bronchoalveolar duct (see inserts). Es, esophagus; Lu, lung; Tr, trachea; Fg, foregut. Sections
are frontal and scale bars are 50 μm (B), 100 μm (A, C–F) and 500 μm (E).
298 C. Gontan et al. / Developmental Biology 317 (2008) 296–309an hour after birth. When born by caesarian section at 18.5d of
gestation, they were gasping for air and unable to oxygenize their
blood.
Examination at E 15.5 and 18.5 showed that their lungs were
smaller, contained enlarged airspaces and a marked decrease in the
number of airways (Figs. 2A–G), especially in the periphery of the
lobes. The abnormalities caused by Sox2 overexpression were even
more pronounced in homozygous Sox2 transgenic lungs (compare
Fig.1F with Fig.1G), showing a devastating, global lung defect. Theseenlarged airspaces were in contact with the trachea as pups born by
caesarian section ﬁlled their lungs with air (not shown). However, the
gas exchange surface is either too small, or oxygenation of blood is
impossible due to structural changes. The presence of the four right
lobes and one left lobe indicated that initial branching is unaffected,
but the strong reduction of the number of primitive alveolar structures
suggested that later branching is impaired.
The airspaces had very thin, primitive alveolar walls, composed of
just a few cell layers, and a general airway epithelial dysplasia (Figs.
Fig. 2. Sox2 overexpression leads to abnormal primitive alveolar formation. External appearances of control (A, B, E), heterozygous (C, D, F) and homozygous Sox2 (G) overexpressing
lungs displaying enlarged airspaces and a marked decrease in the number of airways. Low and high power images of sections stained with hematoxylin and eosin from normal (H, K),
heterozygous (I, L) and homozygous transgenic lungs (J, M). Note the undifferentiated dysplastic epithelium in the double transgenic (K–M, arrowhead). The sharp boundary between
bronchioles and primitive alveoli in wild-type (K, arrowhead) is absent in the transgenic lungs (L, M). Scale bars: 500 μm (H–J), 50 μm (K–M).
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smaller bronchioli and primitive alveoli was severely hampered (Figs.
2H–J). The columnar epithelium of the bronchioli extends into the
proximal part of the dilated air spaces and gradually changes into a
dysplastic epithelium. The cells lining the enlarged airspaces are fre-
quently cuboidal, but some regions contained multilayered atypical
cells (arrows in Figs. 2L, M). Using the myc epitope present in the
transgenic protein, we revealed that the transgene was already ex-
pressed at an early stage of lung development, E10.5 (Fig. 3D). Total
Sox2 expression in the double transgenic lungs (Figs. 3A–C, G, H)
consists of transgenic Sox2 in both proximal and distal airways (Figs.3D–F, I, J), as well as the endogenous Sox2 in the proximal airways
only (Fig. 1). However, the level varies between cells and the pattern is
certainly not uniform in all cells of the airways (Figs. 3D, E). The lumen
of the enlarged air spaces often contained cellular debris, that could
originate either from shredded skin epithelial cells that are inhaled by
fetal breathing movements, or by shredding of airway epithelial cells
(inserts, Figs. 3H, J).
Next, we tested whether the initial effects on epithelial branching
and differentiation in the Sox2 overexpressing lungs could be
reversed when doxycycline was administered for different time
periods. Indeed, when doxycycline treatment was started at the
Fig. 3. Transgenic Sox2 extends expression pattern to the distal lung. Comparison of
total (Sox2; A–C, G, H) and transgenic Sox2 (Myc epitope; D–F, I, J) expression from
E10.5 to E18.5 in Sox2 overexpressing lungs. Sox2 staining was increased throughout
much of the respiratory epithelium at E16.5 and E18.5 (G–J). Sox2 impaired branching
morphogenesis and caused formation of dilated airspaces (asterisks in panels G, H).
Note the difference in expression level and pattern of transgenic Sox2 protein in the
airways. Es, esophagus; Lu, lung; Tr, trachea; Fg, foregut. Sections are frontal and scale
bars are 50 μm (A, D), 100 μm (B, C, E, F, G, I) and 500 μm (H, J).
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showed only small airsacs at the periphery of the lung (Figs. 4C, G).
This indicates that the initial bronchial tree has developed normally,
but is only disturbed by Sox2 overexpression later in development,
resulting in the formation of airsacs at the periphery. Sections of
these lungs revealed the absence of big airsacs, but the formation of
primitive alveoli is hampered throughout the lung (Fig. 4G). When
mice were fed doxycycline from the onset of lung development until
the pseudoglandular phase, it appears that the lungs of the double
transgenic mice recover partially from the Sox2 overexpression, asshown by the formation of small primitive, alveolar structures at the
periphery (arrow in Figs. 4D, H).
Since the affected lungs clearly showed impaired branching at
E12.5, we investigated genes that are expressed at branching sites.
Whole-mount in situ hybridizations of E12.5 lungs showed no dif-
ference in expression between control and affected lungs of the bran-
ching inducing gene, Fgf10 (Bellusci et al., 1997b; Weaver et al., 2000),
which was expressed in the mesenchyme around the lung buds, and
its receptor, Fgfr2, whichwas expressed in the airway epithelium (data
not shown). The Fgf10 responsive genes, Shh and Bmp4 (Bellusci et al.,
1997a; Weaver et al., 1999), were expressed in the epithelium of the
outgrowing buds (Figs. 5A–D and E–H, respectively). However, the
expression of Bmp4 seems reduced, although the area of expression is
extended around the expanded airspaces (compare arrowheads in
Figs. 5G, H). Quantitative PCR analysis of Bmp4 did not show differ-
ences in total level of expression between non-affected and affected
lungs, which supports the ﬁnding of the in situ hybridization (Figs. 5E–
H; data not shown). Since Bmp4 is implicated in a negative feedback
loop to counteract the branch outgrowth, this result could indicate a
possible role for Bmp4 in the occurrence of the dilated airspaces.
Therefore, we analyzed downstream mediators of Bmp and Fgf signa-
ling with antibodies against the phosphorylated forms of SMAD1/5/8
and ERK1/2 (Phospho-p44/42 MAP Kinase), respectively (Figs. 5I–N).
Control lungs showed clear, nuclear pERK staining in the tips of the
growing airways, corresponding to active Fgf signaling (Fgf10), but no
nuclear pSMAD staining was observed in the tips (Fig. 5K, arrowheads
in M). However, in the Sox2 overexpressing lungs, no clear nuclear
staining of pERK in the tips of the airways was observed, instead more
nuclear pSMAD positive cells were present (Figs. 5L, N). Equal num-
bers of pSMAD positive cells were detected throughout the mesench-
yme in both control and affected lungs (Figs. 5K, L).
Since the lungs appear to have a comparable phenotype to that seen
when Bmpr1a or Nmyc is conditionally deleted, we investigated the
proliferation and apoptosis in the Sox2 overexpressing lungs using
antibodies directed against the phospho Histone H3, which detects
cells in themitotic phase of the cell cycle, and against the cleaved form
of caspase3, which detects cells that are undergoing apoptosis (Eb-
laghie et al., 2006;Okubo et al., 2005). Very fewapoptotic cells could be
detected in lung tissue of controls and Soxoverexpressors, even if some
positive cells were present in the lumen of the affected lungs
(arrowhead, Figs. 6C, D, H, I). Although not statistically signiﬁcant,
the Sox2 overexpressing lungs seem to have a slight reduction in
proliferation, which could account for the reduced size of the affected
lungs (Figs. 6E, F, J, K; quantiﬁcation, Figs. 6G, H; lung size, see Figs.
2E–G).
Epithelial differentiation of Sox2 overexpressing lungs
Double transgenic lungs were subsequently analyzed with several
lung-speciﬁc markers to identify whether the epithelium still con-
tained differentiated cells (Fig. 7). The general lung epithelial marker
Ttf1 appeared to be expressed in nearly all epithelial cells of the
double transgenic lungs (Figs. 7A, B). Thus, Sox2 and Ttf1 are not mu-
tually exclusive in airway epithelium, contrasting the reciprocal ex-
pression pattern in trachea and esophagus (Que et al., 2007). Respi-
ratory epithelial cells (Foxa2), type II pneumocytes (Sftpc), ciliated
cells (β-tubulin) and type I pneumocytes (T1α) are present in the
double transgenic lungs, showing that differentiation of cells along the
proximo-distal axis of the airway epithelium was still possible (Figs.
7C–J). The expression of the proximal Clara cell marker CC10
(Scgb1a1) extended into the enlarged airsacs, indicating that the
border between the proximal airways and the distal airways is not as
distinct as in control lungs, but seemed to bemore gradual (Figs. 8A, B,
arrowheads). Several other epithelial markers, SftpA, SftpB, Aqp5 and
Scgb3a1, were also analyzed by RT-PCR, conﬁrming our ﬁnding that
epithelial cells are still able to initiate differentiation into several
Fig. 4. Effect of different time frames of Sox2 induction. Sox2 was induced at different time points by manipulating the doxycycline administration, as indicated in panel A. External
appearance and hematoxylin and eosin staining are shown for controls (B, F), Sox2 induced from the pseudoglandular phase onward (C, G), Sox2 induced until the pseudoglandular
phase (D, H) or Sox2 induction throughout lung development (E, I). Note the clear differences in the degree of branching defects (arrowheads, C, D, E). All lungs were harvested by
caesarian section at 18.5 days of gestation. Sections are frontal and scale bar is 200 μm.
Fig. 5. Bmp4 expression is reduced around affected airways. Whole-mount in situ hybridization for Shh and Bmp4 in embryonic E12.5 lungs of control and double transgenic lungs.
Epithelial Shh expression in double transgenic (B, D) lungs is comparable to that of control lungs (A, C). Epithelial Bmp4 expression is reduced around dilated airspaces in Sox2
overexpressing lungs (F, H, arrowhead) compared to control (E, G, arrowhead). Sequential sections of E12.5 control (I, K, M) and affected (J, L, N) lungs were stained with Sox2 (I, J),
phospho-SMAD1/5/8 (K, L) and phospho-ERK1/2 (M, N). Note the clear difference in nuclear pERK1/2 and pSMAD1/5/8 staining between controls and affected lungs (K versus L, M
versus N, arrowheads). Scale bar: 50 μm.
301C. Gontan et al. / Developmental Biology 317 (2008) 296–309
Fig. 6. Apoptosis and proliferation in Sox2 overexpressing lungs. E12.5 and E18 lungs were analyzed for apoptosis and proliferation using antibodies against the cleaved caspase3 (C,
D, H, I) and phospho-Histone H3 (E, F, J, K), respectively. Sequential sections of E12.5 were stained with Sox2 (A, B). Proliferative cells in the epithelium of E12.5 and total E18.5 lungs
were quantiﬁed by counting 3 microscopic ﬁelds. The number of lungs counted is indicated in parentheses and the results are means±SEM.
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also did not observe changes in expression between control and Sox2
overexpressing lungs of three genes involved in host defense, Acid
chitinase, LysozymeM and LysozymeP (not shown).
The development and integrity of the pulmonary vasculature were
analyzed by crossing the Tie2-LacZ transgenic mouse reporter line
(Schlaeger et al., 1997) with the pTT-myc-sox2 and SPC-rtTA lines.
Whole-mount lacZ staining showed that vessels still encompass the
dilated airways and are connected to the major pulmonary arteries
(Figs. 8C, D). However, these vessels seem to sprout less frequently
compared to non-transgenic littermates, but capillaries containing
erythrocytes could even be detected in the thinnest part of the airsac
mesenchyme (Figs. 8E, F, arrows). The integrity of the vessels appeared
to be intact as no edema or leakage of blood cells was observed. Mus-
cularization of the airways and vasculature extended more distally
than in control lungs (Figs. 8G, H). The enlarged airsacs have signi-
ﬁcantly more α-SMA positive staining than the primitive alveolar
structures of control lungs, indicating that the proximal part of the
airways has expanded more distally, supporting the ﬁnding of CC10
positive cells in the upper part of the enlarged airsacs. It could also be
that these dilated airspaces are proximal airways that failed to form
distal airways.
Three Sox2 overexpressing lungs and three control lungswere used
for microarray hybridization (data not shown). One of the strongest
upregulated genes in the double transgenic lungs is cGRP, a marker for
neuroendocrine cells. Double transgenic lungs had a signiﬁcant
increased number of neuroepithelial cells and neuroepithelial bodies
as shown by the presence of cGRP protein (Figs. 9A, B, compare to
transgene co-expression in Fig. 9C). Other typical neuroendocrine cell
markers, like chromogranin A and secretogranin V, were also signi-
ﬁcantly upregulated in the double transgenic samples (not shown).
Interestingly, neuroendocrine cells are the ﬁrst committed cells emer-
ging during lung development (Warburton et al., 1998). The micro-
arrays also showed that the proneural bHLH gene Mash1 was signi-
ﬁcantly upregulated.Mash1drives epithelial cells into neuroendocrine
cell fate and Mash1 knockout mice lack neuroendocrine cells (Borgeset al., 1997; Ito et al., 2000). Sox2 was shown to be involved in the
upregulation of Mash1, which in turn induces Sox21 (Bylund et al.,
2003; Kiernan et al., 2005; Sandberg et al., 2005). Indeed, Sox21 is
speciﬁcally upregulated as shown by RT-PCR (Fig. 10A). Cells expres-
sing the cGRP marker have lost the transgene expression, as shown by
the absence of double positive cells. This indicates that the differentia-
tion of epithelial cells into the neuroendocrine lineage looses expres-
sion of the SPC transgenic promoter. In addition, the Notch ligand Dll3,
a target of Mash1, is also upregulated (Casarosa et al., 1999). Notch
signaling is implicated in a process called lateral inhibition, in which
cells committed to become neuroendocrine cells prevent neighboring
cells from turning into the same cell fate. The Notch receptor is ex-
pressed in the non-neuroendocrine cells, and the neuroendocrine cells
subsequently produce Notch ligands in aMash1 dependentmanner. In
this respect, it is interesting that we also detected a strong increase in
the expression of Dner, which is described as a neuron-speciﬁc Notch
ligand (Eiraku et al., 2005). We did not ﬁnd an altered expression of
Sox4 and Sox9 (Fig.10A) and based on themicroarrays, further analysis
of other Sox genes, like Sox17, was not required.
Based on the microarray analysis, we found in the Sox2 over-
expressing lungs a signiﬁcant increase of p63, a homologue of p53,
which is involved in development and maintenance of stratiﬁed epi-
thelia. p63 knockout mice die soon after birth without skin and epi-
thelial appendages (Mills et al., 1999; Yang et al., 1999). In the
development of the esophagus, trachea and bronchial epithelium p63
controls the switch from early stem cells to basal cells and their
maintenance (Daniely et al., 2004). In control lung samples, p63 was
only expressed in the basal cell layer of the tracheal epithelium (insert,
Fig. 9D), whereas in double transgenic lungs, p63 expression was
extended into the epithelia of the bronchioli and enlarged airspaces
(Figs. 9D, E) supporting theﬁndings that high Sox2 levels coincidewith
high p63 levels (Que et al., 2007). Staining sequential sections showed
indeed that the transgenic Sox2 was co-expressed with p63 (Figs. 9E,
F). The p63 gene has two different promoters leading to two major
isoforms, onewith theN-terminal transactivation domain (TAp63) and
one without (ΔNp63). It appeared that in the double transgenic lungs
Fig. 7. Expression of epithelial differentiation markers in Sox2 overexpressing lungs.
Expression of Ttf1 (A, B), Foxa2 (C, D), Sftpc (E, F), β-tubulin IV (G, H) and T1α (I, J) in
normal and Sox2 overexpressing lungs at E18.5. Sites and extent of expression were
comparable between controls (A, C, E, G, I) and Sox2 overexpressing lungs (B, D, F, H, J).
Asterisks indicate the dilated airspaces, occasionally ﬁlled with debris. Scale bars:
100 μm.
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isoform is not expressed (not shown). TheΔNp63 isoform is believed to
play a role in themaintenance of the proliferative potential of the basal
layer in the epithelium, ﬁtting the idea that Sox2 drives cells into a
committed progenitor stage (Candi et al., 2007; Daniely et al., 2004).
p63+/Krt14− cells are pre-basal cells, constituting an intermediate,
precursor cell for the p63+/Krt14+ basal cells. In trachea, the normal
side of p63 expression (see insert, Fig. 9D), Krt14 staining appeared
around the nuclei of the p63 positive cells (Fig.10F), indicative for basal
cells, whereas in the distal cells the staining was absent (Fig. 10D). In
the double transgenic lungs, Krt14 was not expressed in the p63
positive cells (Fig. 10E), suggesting that pre-basal cells (p63+, krt14−)
are present in the dilated airspaces with exogenous p63 expression,
which is in line with our observations that Sox2 induces the appear-
ance of committed progenitor cells. We also found upregulation of
genes normally expressed in secretory cells of the posterior glandular
stomach, Tff3, and intestine, Muc5b (Fig. 10A). In addition, Agr2 (post-
erior stomach and intestine) and Reg3g (intestine) showed a drastic
increase by microarray analysis, but are only slightly elevated in thelungs of Sox2 overexpressing mice by RT-PCR. PAS staining revealed
that more glycogen containing cells were present in the epithelium of
the Sox2 overexpressing lungs, conﬁrming the immature phenotype
(Figs. 10B, C). These markers, in combination with high p63 and high
Sox2, show that the affected lung epithelium has obtained epithelial
cells with a gastric phenotype, even though there is no clear gastric
epithelial morphology. We also found high levels of Dcpp, which re-
cently was shown to be expressed in the submucosal glands origi-
nating from the tracheal epithelium (Okubo and Hogan, 2004).
Discussion
Sox2 is a transcription factor that plays a key role in cell fate
decisions in a variety of cell types, like ES cell maintenance, neural
progenitor speciﬁcation, cochlear prosensory and neuronal speciﬁca-
tion, endodermal progenitor differentiation in the taste bud, and lung
epithelium differentiation (Avilion et al., 2003; Bylund et al., 2003;
Graham et al., 2003; Kiernan et al., 2005; Okubo et al., 2006; Pevny
and Placzek, 2005; Que et al., 2007; Taranova et al., 2006). Recent
studies with hypomorphic Sox2 mouse mutants with esophageal
atresia and tracheoesophageal ﬁstulas showed that the level of Sox2
expression is important in the development of the esophagus and
trachea (Que et al., 2007). Loss and gain of function experiments add-
itionally showed that Sox2 is crucial for the development of taste bud
sensory cells (Okubo et al., 2006), while Sox2 levels are also important
during the development of the sensory organ in the mammalian inner
ear (Kiernan et al., 2005). Here we show that overexpression of Sox2 in
the airway epithelium leads to reduced branching of the airways.
Although the initial branches are formed, subsequent branching is
severely hampered, leading to dilated airspaces.We also show that the
differentiation of the epithelial cells is affected, indicating that the
expression level of Sox2 is critical in the differentiation of the pul-
monary epithelium.
Sox2 and pulmonary branching morphogenesis
Sox2 expression is strictly regulated at sites where airways start to
branch. Forced overexpression at these sites affects branching capacity
of the airways, leading to a severely reduced number of airways (Fig.
2). However, the primary bronchial tree develops normally, so initial
branching is not affected by the Sox2 transgene. At this early deve-
lopmental stage, the level or distribution of transgenic Sox2 is not
sufﬁcient to prevent branching and epithelial cells are already en-
tering the branching process at the time the transgene is switched on.
Hence, cells may not have been triggered yet by exogenous Sox2 to
differentiate into a branch-unresponsive cell, but instead remain
committed to branching. At later stages, more cells express Sox2 and
are inﬂuenced by Sox2 effects, leading to the observed branching
defects. Mice homozygous for the Sox2 transgene (Fig. 2G), with
higher Sox2 levels, have a more severe phenotype indicating that the
level of expression is indeed important in blocking the branching
process. The presence of morphologically normal airways in the
heterozygote Sox2 overexpressors (Fig. 2I) is most likely due to the
incomplete penetrance of the SPC-rtTA transgene.
How Sox2 is able to prevent cells from responding to branch-
inducing signals is still elusive and under investigation. Expression
analysis of the branch-inducing growth factor Fgf10 and its receptor,
Fgfr2 showed no differences between control and Sox2 overexpressing
lungs (data not shown), in accordance with Fgf signaling being up-
stream of Sox2 (Que et al., 2007). However, the expression level of the
branch inhibitory gene Bmp4 was reduced, although the region of
expression expanded around the dilated airsacs (Fig. 5). Since Bmp4
inhibits branching in the lung tips, it could be that the reduced
expression contributes to the occurrence of dilated airsacs through the
lack of inhibition of branch outgrowth. Therefore, signaling by Fgf and
Bmp was analyzed using antibodies against the phosphorylated forms
Fig. 8. Clara cells, vessels and muscularization in Sox2 overexpressing lungs: (A, B) Staining for CC10, a Clara cell marker, was expanded into the enlarged airsacs (arrowhead, B). LacZ
staining shows Tie2-driven β-galactosidase expression in control (C) and Sox2 overexpressing (D) lungs. Note reduced sprouting of vessels in double transgenic lungs (arrows). Fli-1
staining shows the presence of small capillaries surrounding the distal dilated airways, indicating the integrity of the vasculature (E, F). Larger vessels and the main airways are
muscularized in controls (G), Sox2 overexpressing lungs showed an increase in the muscularization of the main airways, the vasculature and the enlarged airsacs (H, arrowheads).
Scale bars: 100 μm.
304 C. Gontan et al. / Developmental Biology 317 (2008) 296–309of the downstream mediators ERK1/2 and Smad1/5/8, respectively. In
contrast to the controls, nuclear pERK1/2 was virtually absent from
the very tips, indicating that Fgf signaling in the Sox2 overexpressing
lungs was hampered (Figs. 5M, N). Although Bmp4 is expressed in the
epithelium of control lungs, there is no detectable pSMAD1/5/8 in the
very tip of the lung buds (Figs. 5E, G, K). This is in contrast with the
Sox2 overexpressing lungs where the level of Bmp4 mRNA is reduced
in the epithelium of the affected lung buds (Figs. 5F, H), but phos-
phorylated SMAD1/5/8 proteins are expressed in a subset of epithelial
cells of the tips (Fig. 5L). However, paracrine Bmp4 signaling is not
hampered, because we do detect equal numbers of pSMAD1/5/8/
positive cells in the mesenchyme of both control and Sox2 over-
expressing lungs. This suggests that, in spite of the presence of Bmp4
mRNA, autocrine signaling in the epithelial cells of the branching tips
is subject to other signaling cues or cofactors, present in the Sox2overexpressing cells, but absent in the tip cells in control lungs. The
exact nature of this signaling process and the role of Sox2 in this
mechanism are under investigation. Although it is presently not clear
how the expression of Bmp4mRNA correlates with the presence of the
phosphorylated forms of SMAD1/5/8, it is evident that in the bran-
ching tips of the Sox2 overexpressing lungs the expression of
pSMAD1/5/8 is enhanced as compared to the controls. This ﬁts the
hypothesis that Sox2 overexpressing epithelial cells are unresponsive
to branch-inducing signals and that Sox2 prematurely forces cells in
the tips of the affected lungs into a more differentiated stage. Pre-
liminary data from fetal lung explants showed that overexpression of
Sox2 also inhibits branching in vitro. Culturing control and affected
embryonal lungs in the presence of Fgf10 soaked beads revealed that
the affected lungs do respond to the Fgf10, but the response is initiated
later compared to control lungs. The affected epithelium does respond
Fig. 9. Sox2 overexpression results in the increase in neuroepithelial cells and (pre-) basal cells. Staining of cGRP (A–C), p63 (D–F) and myc epitope (C, F) in lungs at E18.5 from control
(A, D) and Sox2 overexpressing mice (B, C, E, F). cGRP positive staining (neuroepithelial cells) was only detected at the bronchoalveolar ducts in controls (A, arrowheads), and p63
(basal cells) was only expressed in the basal cell layer of the trachea (D, inset). Increased staining for cGRP (B) and p63 (E) was detected in the abnormal airway epithelium expanding
into the enlarged airspaces. Note that cGRP positive cells are negative for the Sox2 transgene (C), while Sox2 transgenic expression colocalizes with p63 (E, F). Note that there is no
myc-epitope expression in the control lungs (C, insert). Scale bars: 100 μm.
305C. Gontan et al. / Developmental Biology 317 (2008) 296–309to the Fgf10, because the overexpression of Sox2 is not uniform and
the epithelial cells not overexpressing Sox2 are able to respond to
Fgf10.
The Sox2 overexpressing lungs appear to have a comparable
phenotype to that seen when Bmpr1a or Nmyc are conditionally
deleted (Eblaghie et al., 2006; Okubo et al., 2005). Recently, Shu et al.
(2005) demonstrated by inhibiting Wnt/β-catenin signaling that Wnt
signaling is upstream of Bmp, Nmyc and Fgf. In addition, Que et al.
(2007) showed that Fgf10 signaling is upstream of Sox2 and negatively
inﬂuences its transcription. Therefore, we hypothesize that Wnt and
Fgf signaling has no (direct) inﬂuence on the Sox2 overexpression
phenotype described. We did not observe differences in β-catenin
staining pattern between lungs from controls and Sox2 overexpres-
sors (data not shown). Nmyc is expressed in the proliferative cells of
the distal epithelium, and overexpression leads to a loss of the distinct
Sox2 boundary between the terminal bronchioli and the future alveoli,
which is normally observed. This indicates that the expansion of pro-
liferative cells diminishes the number of Sox2 positive cells, and thus
the number of committed cells. When Nmyc is deleted from the ep-
ithelium, the gross appearance of the lungs resembles the over-
expression of Sox2 phenotype. This could be due to the fact that cells
are not longer maintained in the proliferative stage, but rather are
initiating a differentiation program.
Bmp4 is expressed as the lung starts to branch, and may be
required to keep cells proliferating, and prevent them from premature
differentiation. Inhibiting Bmp4 signaling in the lung by conditional
deletion of BmprIa results in a proximalization of the lung, resemblingthe Sox2 overexpressing lungs. This could indicate that Sox2 and
Bmp4 have antagonistic effects, but this is merely speculative. Bmp4,
like Nmyc, would maintain the cells in branching regions in a branch
responsive stage, to allow them to branch again. Moreover, Nmyc
expression is reduced in the conditional BmprIa mutant, suggesting
that cell proliferation and survival in part are regulated through the
synergistic action of Bmp and Nmyc. Sox2 on the other hand, will drive
cells into the differentiation program and a loss to respond to branch
inducing agents. However, the precise role of Bmp4 in early lung
development is still elusive, because of contradictionary results
obtained (Eblaghie et al., 2006; Cardoso and Lu, 2006). Overexpression
of Bmp4 in lung epithelium results in a phenotype comparable to the
BmprIa conditional mutant (Bellusci et al., 1996). Moreover, SPC
promoter-driven overexpression of Noggin or Gremlin, two antago-
nists of Bmp, resulted in smaller lungswith a proximalized phenotype,
slightly different from the BmprIa mutant (Lu et al., 2001; Weaver
et al., 1999). These results indicate that the level of Bmp4 expression is
critical for its activity and effect on cells.
So, both Nmyc and Bmp4 are necessary to maintain cells in a pro-
liferative and branch responsive state early in lung epithelial bran-
ching, whereas Sox2 is expressed in cells that are committed for dif-
ferentiation. Whether Nmyc, Bmp4 and Sox2 act in the same pathway
to counteracts each other’s function, or in parallel pathways that are
inﬂuenced independently remains to be resolved.
The observation by Que et al. (2007) that Sox2 expression is upre-
gulated in the Ttf1 (Nkx2.1) knockout mice, which has a failure to
separate the foregut into trachea and esophagus, supports our ﬁnd-
Fig. 10. Differential expression of speciﬁc markers. (A) Semi-quantitative RT-PCR for expression of Sox2 (endogenous and transgene), myc-Sox2 (transgene-speciﬁc), Sox21, Sox9, Sox4
(Sox family), ΔNp63 (p63 isoform), Tff3, Muc5B, Agr2, Reg3g, Dcpp, Dll3 (gastric/intestinal markers), SftpA, SftpB, Aqp5, CC10, Scgb3a1 (lung epithelial markers) and Wnt5a, Wnt7b
and HPRTwas performed on RNA isolated from three control and three double transgenic E18.5 lungs. Note the signiﬁcant increase of Sox2 in double transgenic lungs. Upregulation of
Sox21, ΔNp63, Tff3,Muc5B, Agr2, Reg3g, Dcpp and Dll3 conﬁrmed our microarray data. PAS staining at E18.5 showed a marked increase in Sox2 overexpressing lungs (C) compared to
controls (B). Keratin14 is absent in distal airways in control and double transgenic lungs (D, E), but present in tracheal epithelium (F). Sox2 is expressed in both epithelia (D–F, inserts).
Tr, trachea. Scale bars: 100 μm (B, C), 50 μm (D–F).
306 C. Gontan et al. / Developmental Biology 317 (2008) 296–309ings. Normally, Ttf1 and Sox2 have a reciprocal expression pattern in
the esophagus/trachea (Fig. 1A, insert) and the Ttf1 mouse mutant
ectopically expresses Sox2 in the ventral part of the foregut. As a
result, the primary lung buds do not branch into subsequent airways,
but instead form air sacs, supporting our data that downregulation of
Sox2 is necessary for the lung epithelium to branch (Minoo et al.,
1999).
Overexpression of an inducible Sox17 transgene with the SPC-rtTA
resulted in reduced branching morphogenesis, dilated tubules and
decreased differentiation of distal epithelium (Park et al., 2006).
However, the Sox17-induced defects are less severe than in the Sox2
overexpressing lungs. We also observed dilated tubules, but these
tubules end in enlarged airspaces, whereas the sox17 lungs develop
some alveolar structure. In contrast to their observation, we did not
observe changes in the number of type I and type II pneumocytes.
Differences in the effects of overexpressing Sox17 may result from the
fact that endogenous Sox17 is only expressed in the mesenchyme and
primary vessels. It is not until gestational age 18 that Sox17 is detected
in the bronchioles. The observation that Sox17 induces an increase in
the number of neuroepithelial cells could be caused by overlapping
activities of Sox17 and Sox2. However, conditional deletion of Sox9 in
the developing airways did not lead to overt morphological changes,
so other Sox family members may have overlapping functions (Perl
et al., 2005).
Sox2 and epithelial differentiation
The pulmonary epithelium of Sox2 overexpressing mice contains
elevated levels of committed progenitors, like neuroendocrine cells
and p63 positive cells. The neuroendocrine cells are the ﬁrst type ofcells that emerge during development and are partly a transient cell
type, while the p63 positive cells are mainly expressed in the basal,
progenitor-type of cells (Candi et al., 2007; Reynolds et al., 2000;
Warburton et al., 1998). In other organ systems, like the developing
neural tube, cochlea and tongue, overexpression of Sox2 leads to an
increase of committed progenitor cells and a reduced number of fully
differentiated cells (Bylund et al., 2003; Graham et al., 2003; Kiernan
et al., 2005; Okubo et al., 2006; Pevny and Placzek, 2005; Que et al.,
2007). This supports our ﬁndings that Sox2 drives epithelial cells
prematurely into a committed progenitor cell type, resulting in cells
with sustained Sox2 expression that are not responsive to branch-
inducing agents. They are still able to differentiate into the various
lung-speciﬁc cell lineages due to other signaling cues. While cells are
differentiating, the transgene can be switched off in certain lineages,
as we and others have observed (see double staining in Fig. 9C; Okubo
and Hogan, 2004; Park et al., 2006).
Neuroendocrine cells
The increase in the number of neuroendocrine cells parallels the
microarray results that the cGRP and proneural gene Mash1 are
considerably upregulated. Like in the inner ear (Kiernan et al., 2005),
Sox2 upregulates Mash1 expression in lung epithelium and subse-
quently drives cells into the neuroendocrine fate (Borges et al., 1997;
Ito et al., 2000). Bylund et al. (2003) showed that B1 Sox genes (Sox 1–
3) keep neural cells undifferentiated by blocking the downstream
targets of pro-neural genes. Sandberg et al. (2005) showed that
proneural genes induced Sox21 expression and Sox21 has the opposite
effect on neural development. It counteracts the activity of Sox2, thus
the Sox2/Sox21 balance determines whether neural cells remain
307C. Gontan et al. / Developmental Biology 317 (2008) 296–309progenitors or start to differentiate. Strikingly, we found a strong
induction of Sox21, suggesting that a similar mechanism is active in
the formation of neuroendocrine cells. The Sox2 transgene is
expressed from the SPC promoter, and hence Sox21 cannot switch
off the Sox2 transgene, but neuroendocrine cells loose SPC promoter
activity (Fig. 9C).
Overexpression of Mash1 in airway epithelium using the CC10
promoter leads to a generalized epithelial dysplasia and focal hyper-
plasia, which resembles some of our ﬁndings (Linnoila et al., 2000).
This phenomenon is attributed to a disturbed balance between sus-
tained proliferation in terminal bronchioles and resistance to apop-
tosis (Wang et al., 2007). Furthermore, the observed hyperplasia
resembles a human condition known as bronchiolization of alveoli
(BOA), a premalignant lesion of human lung carcinomas. Close exam-
ination of the dilated air sacs in our Sox2mice showed that indeed the
most proximal part of these alveolar structures resembled the phe-
notypic characteristics of the Mash1 overexpressing mice. Interest-
ingly, the authors found that although overexpression of Mash1 leads
to hyperplasia and metaplasia of the airway epithelium, no overt
neuroendocrine differentiation was observed. This could be caused by
the fact that these authors used the CC10 promoter, which is ex-
pressed at later stages and in different cells than the SPC promoter.
Neuroendocrine hyperplasia was also observed in a variety of con-
ditions, including hypoplasia of the lung in case of bronchopulmonary
dysplasia, congenital diaphragmatic hernia and sudden infant death
syndrome (Warburton et al., 1998).
p63 overexpressing cells
Overexpression of Sox2 in airway epithelium leads to a dramatic
increase in the number of p63 expressing cells. Two groups showed
that p63 plays a critical role in the development of stratiﬁed epithe-
lium (Mills et al., 1999; Yang et al., 1999). Two different promoters lead
to two major isoforms, one with an N-terminal Trans Activation do-
main (TAp63), and one without this domain (ΔNp63). Sox2 over-
expression induces ΔNp63 expression, which is implicated in the
maintenance of the proliferative potential of basal cells (Candi et al.,
2006). However, another group indicated that ΔNp63 is necessary to
counteract the TAp63 activity in order for cells to differentiate (Koster
et al., 2004). In spite of the ongoing debate, partly caused by the usage
of different approaches and mouse strains, most data seem to point at
the fact that the ΔNp63 isoform is expressed and mandatory in aFig. 11.Model of Sox2 action. Airway epithelial cells express Sox2 before they are induced to
preparing cells to branch (naive). After branching, cells start to express Sox2 again and
differentiation pathways (box, top right). Overexpression of Sox2 prematurely drives cells in
right), rendering these cells insensitive to branch inducing signals. See Discussion for a detaprogenitor or committed precursor cell (Candi et al., 2007; Koster
et al., 2007). This supports our ﬁndings that overexpression of Sox2
leads to a premature differentiation of cells into committed progeni-
tors. In addition, Que et al. (2007) found a correlation between the
level of Sox2 and p63, inversely correlating with Ttf1 expression in the
esophagus.We clearly observe a high number of Sox2 and p63 positive
cells, but Ttf1 is still expressed, indicating that ectopic overexpression
of Sox2 may not necessarily result in a downregulation of Ttf1 in
the lung.
Intestinal cells
Our microarray data unexpectedly showed genes that were cha-
racteristic for secretory cells of the posterior glandular stomach and
intestine, like Tff3, Muc5B, Agr2 and Reg3g. In the esophagus of mice
that express reduced amounts of Sox2, the same markers are
expressed, except for Tff3 (Que et al., 2007). Although the esophagus
epithelium differs from the airway epithelium, it is striking to observe
the same genes to be upregulated. However, in mice that develop a
tracheoesophageal ﬁstula, which have the most severe reduction of
Sox2 expression, it seems that these gastric markers are not promi-
nently expressed (Que et al., 2007). In addition, overexpression of an
upstream mediator of Sox2 expression, β-catenin, resulted in an in-
crease of the same type of gastric and intestinal marker genes (Okubo
and Hogan, 2004).
Concluding remarks
Our data clearly show that overexpression of Sox2 leads to a block
in the ability of the airways to branch and form bronchial–alveolar
structures. Furthermore, differentiation of the epithelium is abnormal
and forced Sox2 expression results in formation of progenitor cells.
We propose that Sox2 prematurely induces cells into a differentiation
program, like neuroendocrine and (pre-) basal cells, thereby rendering
these cells unresponsive to branch-inducing signals and causing a
developmental arrest (Fig. 11). This phenotype agrees with previous
Sox2 overexpressing studies in the neural tube, eye, cochlea and
tongue, where elevated numbers of precursor or committed progeni-
tors were detected (Bylund et al., 2003; Graham et al., 2003; Kiernan
et al., 2005; Okubo et al., 2006; Pevny and Placzek, 2005; Que et al.,
2007). The premature commitment of cells, however, does not lead to
an absence of differentiation of neighboring cells like Clara cells,branch (progenitor). Fgf10 was shown to downregulate Sox2 (Que et al., 2007), thereby
become either progenitor, which can branch further, or committed, which enters
to committed progenitor cells, like neuroendocrine and (pre-) basal cells (box, bottom
iled description of the pathway.
308 C. Gontan et al. / Developmental Biology 317 (2008) 296–309ciliated cells, type I and type II cells, because the SPC-driven transgene
is silenced in some committed progenitor cells as shown for neuro-
endocrine cells.
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